Mitomics Launches Test for Detecting Prostate Cancer from Negative Biopsies

The laboratory-developed, quantitative PCR-based test is now available to physicians in the US through the company's CLIA lab in Aurora, Colo.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.